Insider Trading & Ownership of Redmile Group, LLC

Location
Larkspur, CA
Summary
The estimated value of insider holdings of Redmile Group, LLC is at least $406,878,706 dollars as of 23 Apr 2026. Redmile Group, LLC is the 10%+ Owner of RayzeBio, Inc. and owns shares of RayzeBio, Inc. stock worth about $116.11M. Redmile Group, LLC is the 10%+ Owner of ADC Therapeutics SA and owns shares of ADC Therapeutics SA (ADCT) stock worth about $105.19M. Redmile Group, LLC is the Director of Absci Corp and owns shares of Absci Corp (ABSI) stock worth about $41.14M. Redmile Group, LLC is the Director, 10%+ Owner of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $39.56M. Redmile Group, LLC is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $31.25M. Redmile Group, LLC is the 10%+ Owner of Zymeworks Inc. and owns shares of Zymeworks Inc. (ZYME) stock worth about $30.58M. Redmile Group, LLC is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. stock worth about $19.37M. Redmile Group, LLC is the 10%+ Owner of Adagio Therapeutics, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $13.39M. Redmile Group, LLC is the Director, 10%+ Owner of Shattuck Labs, Inc. and owns shares of Shattuck Labs, Inc. (STTK) stock worth about $6.92M. Redmile Group, LLC is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $3.36M.
Signature
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Redmile Group, LLC and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Redmile Group, LLC has 14 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $406,878,706.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: RayzeBio, Inc. ($116,106,625).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Redmile Group, LLC

RYZB Forms 3/4/5

RayzeBio, Inc.

Relationship
10%+ Owner
Holdings value
$116,106,625
Past year net change
Change %
Report period
19 Sep 2023
ADCT Forms 3/4/5

ADC Therapeutics SA

Relationship
10%+ Owner
Holdings value
$105,194,110
Past year net change
+$107,144,341
Change %
+102%
Report period
31 Mar 2026
ABSI Forms 3/4/5

Absci Corp

Relationship
Director
Holdings value
$41,142,959
Past year net change
Change %
Report period
12 Jun 2024
ZYME Forms 3/4/5

Zymeworks Inc.

Relationship
10%+ Owner
Holdings value
$30,584,956
Past year net change
Change %
Report period
13 Oct 2022

Insider Transactions Reported by Redmile Group, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .